publication venue for
- Effectiveness of a personalised self-management intervention for people living with long covid (Listen trial): pragmatic, multicentre, parallel group, randomised controlled trial.. 4:-. 2025
- Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies.. 3:-. 2024
- Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study.. 3:-. 2024
- Published research on the human health implications of climate change between 2012 and 2021: cross sectional study.. 3:-. 2024
- Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.. 2:-. 2023
- Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial.. 2:-. 2023
- Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study.. 2:-. 2023
- Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis.. 1:-. 2022